Delivery Order SPE2DB22D9130-SPE2DB23FE0CT
Award Date 1/10/23
Potential Completion Date 1/11/23
Potential Value $553
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order contract valued at two thousand eight hundred seven dollars and sixty cents ($2,807.60) to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The firm fixed price order is for the delivery of four thousand five hundred fifty-nine (4,559) Boostrix Tdap vaccine syringes in 0.5mL quantities by January 13, 2023 in support of the agency's stockpile of essential medical supplies. No set-aside designation was applied to this procurement. DMS...
- This delivery order, awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., is for $2,807.60 worth of Boostrix Tdap vaccine syringes to be delivered to a location in Park Ridge, Illinois. The completion date is January 12, 2023. The contract was awarded on January 11, 2023 under a firm fixed price arrangement. No set-aside designation was used for this order. The Defense Logistics Agency manages the global supply chain for the United States military and supports procurement...
- The Defense Logistics Agency Troop Support Medical (DLA) awarded a $276,400 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 4561543977 doses of Boostrix TDAP vaccine in 0.5mL vials. The place of performance is Park Ridge, Illinois, with deliveries required between July 13-14, 2023. DLA manages the procurement and distribution of medical supplies and equipment for all branches of the U.S. Armed Forces. This delivery order was issued against an existing DLA medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $48.5K to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This firm fixed-price delivery order was awarded on September 18, 2025, with an ultimate completion date of September 19, 2025, and carries no set-aside designation. The contract will be performed in Park Ridge, Illinois, where the vendor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $26,720.88 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on May 16, 2025. The delivery order is for Boostrix TDAP vaccine in 0.5mL syringes, with an ultimate completion date of May 19, 2025. This firm fixed-price delivery order was issued without set-aside designation, leveraging the contractor's established position in the federal pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,988.98 to DMS Pharmaceutical Group Inc. on June 3, 2025, with an ultimate completion date of June 4, 2025. The delivery order is for Boostrix TDAP vaccine syringes in 0.5mL dosages, to be delivered to Park Ridge, Illinois. This contract utilizes a firm fixed-price structure with no set-aside designation. The award represents a single delivery order issued under DMS Pharmaceutical Group's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a $8,486.40 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Boostrix TDAP vaccine in 0.5ml syringe format. The delivery order, issued on January 6, 2026, with an ultimate completion date of January 7, 2026, was awarded without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal...
- DMS Pharmaceutical Group Inc. was awarded a five hundred thirty dollar delivery order against an unspecified contract vehicle to supply four hundred fifty-five thousand nine hundred fifty-seven doses of Boostrix TDAP vaccine in 0.5mL syringes to the Defense Logistics Agency by January 11, 2023. The firm fixed price order was awarded on January 10, 2023 without a set-aside designation. Performance will occur in Park Ridge, Illinois. The Boostrix TDAP vaccine syringes will support the Defense...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,693.82 to DMS Pharmaceutical Group Inc. for the supply of Boostrix TDAP vaccine in 0.5mL syringes. The contract, effective July 23, 2025, with an ultimate completion date of July 24, 2025, represents a delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999 and valid through November 2026. No set-aside designation was applied to this award. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on June 11, 2025, for Boostrix TDAP vaccine syringes in 0.5ml units. The contract is valued at $1,136.56 and carries a firm fixed-price structure with an ultimate completion date of June 12, 2025. This delivery order was issued without a set-aside designation, and performance will take place at the...